Privia Health Group, Inc.

1. 01

   Behind SPY and its sector fund XLV over 1 year

   1 month: +10.5% (SPY −1.6%, XLV +13.5%). 3 months: −6.5% (SPY −0.4%, XLV +15.5%). 1 year: −9.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: PRVA, SPY and XLV · as of 4 Nov 2026

2. 02

   Above its 50-day average, below its 200-day

   The 4 Nov 2026 close of $22.40 was 7.1% above its 50-day average ($20.91) and 1.1% below its 200-day average ($22.64). It has closed below the 200-day for 9 sessions, since 23 Oct 2026. The 50-day average crossed below the 200-day on 16 Sep 2026, 35 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

3. 03

   Volume 2.4× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 2.8M shares was 2.4× the average of the 30 sessions before it (1.2M), as the price rose 4.3%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

4. 04

   35% of the way up its 52-week range

   Closed at $22.40 on 4 Nov 2026: 22.3% below the 52-week high of $28.82 (16 Jul 2026) and 18.4% above the low of $18.92 (24 Sep 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Short interest at 3.9% of shares outstanding

   5.0M shares were sold short at the 15 Oct 2026 settlement, 3.9% of the 127.7M shares outstanding; covering them would take 3.5 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

At the 4 Nov 2026 close